Works matching IS 1021335X AND DT 2022 AND VI 48 AND IP 4
1
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8401
- Nakai, Yasushi;
- Tatsumi, Yoshihiro;
- Hori, Shunta;
- Morizawa, Yosuke;
- Iida, Kota;
- Onishi, Kenta;
- Miyake, Makito;
- Oda, Yuki;
- Owari, Takuya;
- Fujii, Tomomi;
- Onishi, Sayuri;
- Tanaka, Nobumichi;
- Fujimoto, Kiyohide
- Article
2
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8400
- Lu, Yalin;
- Chen, Xingjie;
- Liu, Fang;
- Yu, Hao;
- Zhang, Yu;
- Du, Kangjie;
- Nan, Yang;
- Huang, Qiang
- Article
3
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8399
- Xing, Feng;
- Song, Zhijiao;
- Cheng, Zhongping
- Article
4
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8398
- Komiyama, Takuya;
- Kuroshima, Takeshi;
- Sugasawa, Takehito;
- Fujita, Shin-Ichiro;
- Ikami, Yuta;
- Hirai, Hideaki;
- Tsushima, Fumihiko;
- Michi, Yasuyuki;
- Kayamori, Kou;
- Higashino, Fumihiro;
- Harada, Hiroyuki
- Article
5
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8397
- Si, Yanhui;
- Li, Lei;
- Zhang, Weiwei;
- Liu, Qiling;
- Liu, Baochi
- Article
6
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8396
- Huang, Youwei;
- Wang, Xiangyu;
- Hu, Rendong;
- Pan, Guopeng;
- Lin, Xi
- Article
7
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8395
- Song, He;
- Dong, Ming;
- Zhou, Jianping;
- Sheng, Weiwei;
- Li, Xin;
- Gao, Wei
- Article
8
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8394
- Liu, Xuerong;
- Wang, Yan;
- Zhao, Jinglong
- Article
9
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8393
- Beppu, Takuro;
- Nishi, Koji;
- Imoto, Shuhei;
- Araki, Waka;
- Setoguchi, Itaru;
- Ueda, Ayaka;
- Suetsugi, Naho;
- Ishima, Yu;
- Ikeda, Tokunori;
- Otagiri, Masaki;
- Yamasaki, Keishi
- Article
10
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8392
- Luo, Renhui;
- Xie, Lili;
- Lin, Yingmei;
- Shao, Jun;
- Lin, Zhejing
- Article
11
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8391
- Cao, Xiaozheng;
- Ren, Kaiqun;
- Song, Zhengwei;
- Li, Duo;
- Quan, Meifang;
- Zheng, Yu;
- Cao, Jianguo;
- Zeng, Wenbin;
- Zou, Hui
- Article
12
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8390
- Yang, Kai;
- Liang, Xiaoxiang;
- Wen, Kunming
- Article
13
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8389
- Xu, Lishuai;
- Li, Weidong;
- Shi, Qian;
- Wang, Minfeng;
- Li, Heng;
- Yang, Xiaoli;
- Zhang, Junjun
- Article
14
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8388
- Yin, Binbin;
- Liu, Zhenping;
- Wang, Yiyun;
- Wang, Xuchu;
- Liu, Weiwei;
- Yu, Pan;
- Duan, Xiuzhi;
- Liu, Chunhua;
- Chen, Yuhua;
- Zhang, Yurong;
- Pan, Xiaoyan;
- Yao, Hangping;
- Liao, Zhaoping;
- Tao, Zhihua
- Article
15
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8387
- Hu, Hao;
- Xiang, Yuan;
- Zhang, Xiao-Yu;
- Deng, Yang;
- Wan, Fu-Jian;
- Huang, You;
- Liao, Xing-Hua;
- Zhang, Tong-Cun
- Article
16
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8386
- Tamari, Shigeyuki;
- Menju, Toshi;
- Toyazaki, Toshiya;
- Miyamoto, Hideaki;
- Chiba, Naohisa;
- Noguchi, Misa;
- Ishikawa, Hiroyuki;
- Miyata, Ryo;
- Kayawake, Hidenao;
- Tanaka, Satona;
- Yamada, Yoshito;
- Yutaka, Yojiro;
- Nakajima, Daisuke;
- Ohsumi, Akihiro;
- Hamaji, Masatsugu;
- Date, Hiroshi
- Article
17
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8385
- Zhang, Min;
- Li, Qiongxia;
- Pan, Yingzhe;
- Wang, Hui;
- Liu, Gang;
- Yin, Hui
- Article
18
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8384
- Liu, Cairu;
- Feng, Haiqin;
- Song, Lihong;
- Li, Shuirui;
- Wu, Yiping;
- Yang, Liping
- Article
19
- Oncology Reports, 2022, v. 48, n. 4, p. N.PAG, doi. 10.3892/or.2022.8383
- Wu, Zhiwu;
- Han, Yong;
- Li, Yanyan;
- Li, Xuetao;
- Sun, Ting;
- Chen, Guilin;
- Huang, Yulun;
- Zhou, Youxin;
- Du, Ziwei
- Article